Beyond Compliance: Making Quality a Driver of Operational Performance
Two buzzwords, one missing ingredient Quality Risk Management (QRM) and Operational Excellence may be the two most-used phrases in our industry. They may also be...
Read MoreFDA Quality Management Maturity Program
Drug shortages present a critical threat to the pharmaceutical industry, healthcare systems and patient safety. While the root causes vary, these disruptions are frequently tied...
Read MoreStewardship Over Automation: FDA Redefines AI Accountability in Pharma
In response to a landmark FDA warning, this analysis explores how regulators are shifting from automation to accountable stewardship, redefining governance expectations for AI across...
Read MoreFrom Compliance Burden to Strategic Capability
As global regulations continue to evolve, life sciences organizations face increasing pressure to meet stringent compliance expectations without slowing innovation or compromising product quality. The...
Read MoreSustaining Reliability: Life Cycle Maintenance of AI Models in Drug Development (Part 2 of 3)
Nick Armstrong, Senior Director of Digital Enablement at CAI and co-chair of the ISPE Community of Practice on AI, specializes in the intersection of artificial...
Read MoreInnovative Approaches to Quality and Engineering Management: Transforming Life Sciences Manufacturing
The path to operational excellence is continually being redefined. Today’s manufacturers face mounting pressure to enhance product quality, improve compliance, and optimize operational efficiency—all while...
Read More